Nutrition and immunotherapy for cancer
Part of Cancer, Hormones & metabolism clinical trials.
This trial tests whether adding nutrition support helps cancer patients with malnutrition respond better to immunotherapy. You may be able to join if you have cancer and are malnourished, are generally active, and can swallow pills.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with cancer and are malnourished.
- You are over 18 years old.
- You are able to be up and about (ECOG performance status 0-2).
- Your life expectancy is at least 6 months.
- You have at least one tumor that can be measured on scans.
- You can swallow capsules comfortably.
- If you are a woman able to have children, you must be postmenopausal or use effective birth control.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a special nutrition drink, Fortimel, for people with colorectal, stomach, or lung cancer who are getting chemo, radiation, or immunotherapy. It aims to see if this extra nutrition can help patients who are at risk for malnutrition.
This study tests whether personalized nutrition advice can help people with cancer feel better and have a better quality of life. You would work with a nutrition expert to get a plan tailored to your needs.
This trial looks at how your nutrition status affects the success of immunotherapy drugs in people with advanced esophageal squamous cell cancer or stomach adenocarcinoma that has spread. It aims to find if better nutrition leads to better treatment results.
This trial studies whether adding special nutrition (oral immunonutrition supplements) can help immunotherapy work better in people with metastatic non-small cell lung cancer. Participants receive immunotherapy, with or without chemotherapy, and must be able to take oral supplements.
This study tests whether special nutritional support (called immunonutrition) helps patients with head and neck, lung, or rectal cancer who are receiving chemotherapy, radiation, or immunotherapy. The goal is to see if it improves how well treatment works and how you feel during and after cancer care.
This trial tests if adding a nutrition and exercise program to the medication olanzapine can help improve appetite and quality of life in people with advanced solid tumors. Olanzapine is already sometimes used to boost appetite; this study wants to see if extra support makes it work better.
Hear when a new Nutrition Disorders trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.